Oscar Health (NYSE:OSCR) CEO Mark Bertolini Sells 591,168 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 591,168 shares of the company’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $29.28, for a total transaction of $17,309,399.04. Following the transaction, the chief executive officer owned 8,990,566 shares in the company, valued at $263,243,772.48. This represents a 6.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

Shares of OSCR opened at $29.37 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a 50-day moving average of $23.30 and a 200-day moving average of $17.45. The company has a market cap of $8.85 billion, a PE ratio of -49.78, a P/E/G ratio of 2.08 and a beta of 2.37. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $30.66.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same period in the previous year, the company posted $0.92 EPS. The firm’s revenue was up 52.6% compared to the same quarter last year. On average, equities research analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Analyst Ratings Changes

OSCR has been the topic of a number of research reports. Weiss Ratings lowered Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 24th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Wells Fargo & Company set a $20.00 price target on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Zacks Research downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 5th. Finally, Wolfe Research started coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They issued a “peer perform” rating on the stock. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $20.78.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of OSCR. Jones Financial Companies Lllp boosted its position in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio purchased a new stake in Oscar Health in the 1st quarter valued at $30,000. Fifth Third Bancorp lifted its stake in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after acquiring an additional 1,413 shares in the last quarter. Quarry LP lifted its stake in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of Oscar Health in the 1st quarter worth $49,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.